Going Beyond

Symptom Management.

Who is

Labyrinth Sphere

Labyrinth Sphere is determined to influence therapies for mental health by expanding the boundaries of the standard of care with our evidence-based research.

What We Do

Brain Biohacking Hardware

Brain Biohacking Software

Clinical Trails

Psychodellics plant genome lab

Brain Foods

Clinics

Mission

We will continuously pursue the study of safe and effective alternatives for mental health care. We want to help those in need by promoting health, happiness, and an improved quality of life.

Our Values

Full Transparency

We will provide full transparency for subjects during clinical trials with the application of biotechnology as well as blockchain based tracking technology for all grown substances.

Evidence-Based

We make decisions using evidence-based answers from brain scan studies conducted by industry-leading experts.

Determined To Help

We are determined to help provide safe and quality therapies, promote health transformation, and improve the lives of those who are suffering.

Influential

We want to influence the world to impart legislative changes to access to the best available treatment that is both safe and affordable.

Clinical Trials

We utilize a brain wave and biometrics data collection
process to understand the effects of psychedelics, hemp,
and cannabis to reveal how a brain reacts to treatment
during stress, euphoria, fear, pain, and under other mental
health conditions.

Executive Leadership

Katarina Maloney

Chief Executive Officer

Katarina is a biotechnology leader in business development, strategic operations, supply chain, and product management. She completed two simultaneous bachelor’s degrees in European Studies/Political Science and Foreign Language. She attended leadership programs at Cornell University and Crescom Leadership Training Institute and is experienced in the hemp and cannabis industries.

Michael Pierce,
DC, DACNB

Chief Medical Strategy Officer

Dr. Michael Pierce specializes in neurology, clinical neurochemistry, and neuroautoimmune support for 25 years. Dr. Pierce has a Bachelor of Science and is a professor at Carrick Institute of Clinical Neuroscience and at Northwestern Health Sciences University. He attended Carrick Institute of Clinical Neuroscience for his post-doctorate in Neurology.

Olga Melnik
CPSM, PMP

Chief Operations Officer

Olga Melnik is a business operation, clinical operations, supply chain, logistics, tracking, record and project management, and pharmaceuticals field expert. She holds a Bachelor of Science in Supply Chain Management from Universities in Uzbekistan and the United Kingdom.

Scientific Leadership

Yuri Kropotov, PhD

Chief Medical Officer

Yuri Kropotov is a neuroscientist, book author, and a “Russian Nobel Prize” recipient with award-winning brainwave research earning three doctorates in theoretical physics, philosophy, and neurophysiology.

Bernard Wandernoth, PhD

Chief Engineering Officer

Mrs. Wandernoth is a Switzerland signals engineer of Human Brain Interface (HBI) brain wave database and the EEG and ERP hardware and software system for QEEG and ERP analysis and has extensive international experience in compliance and regulations.

Partnerships

Go83Bar partnership provides recruitment of our clinical trial subjects.

Clinlogix is a Clinical Research Organization providing expertise and support management during our clinical trial systems.

Advarra provides institutional review Board, institutional biosafety committee and global consulting service assist during trials.

COEUS Consulting Group assist will include pharmaceutical product launch and lifecycle management for drug development and market support.

VeChain provides tracking technology to show complete safety, transparency, and accountability to our patients, consumers, regulatory organizations, and the public market.

Investors

Join us by investing in our journey to improve mental health and happiness. Sign up for regular updates, press releases, and announcements that are delivered right to your inbox.